SMC accepts avatrombopag for severe thrombocytopenia

Avatrombopag is accepted for use within NHS Scotland for severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.

Please sign in or register for FREE

No comments yet.